← Back to Search

Autonomic Modulation Training for Stress (AMT Trial)

N/A
Recruiting
Led By Judith P Andersen, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to follow-up (immediate post intervention assessment)
Awards & highlights

AMT Trial Summary

This trial aims to test a web-based training intervention to build resilience and wellness capacity among police officers exposed to PTSI, and examine sex and gender as central determinants of health.

Who is the study for?
This trial is for active duty frontline law enforcement officers in Canada who speak English fluently. It's designed to help police officers build resilience and wellness capacity, potentially reducing symptoms of post-traumatic stress injuries (PTSI).Check my eligibility
What is being tested?
The study tests Autonomic Modulation Training (AMT), a web-based program aimed at improving resilience against stress and trauma. The effectiveness of AMT will be compared to traditional in-person training methods.See study design
What are the potential side effects?
Since the intervention involves non-invasive training techniques, significant side effects are not anticipated. However, participants may experience emotional discomfort or increased awareness of stress during the process.

AMT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to follow-up (immediate post intervention assessment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to follow-up (immediate post intervention assessment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol use
Anxiety symptoms
Burnout symptoms
+24 more

AMT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Participants randomized to the experimental group will complete baseline assessments, the 6 week AMT treatment online and then complete the follow up assessment (8 weeks total)
Group II: ControlActive Control1 Intervention
Participants randomized to the control group will be matched to the experimental group on demographic and outcome measures. Control participants will take the baseline assessments, will wait 7 weeks and take the follow-up assessment (8 weeks total). Control group participants are able to enrol in the AMT intervention at the end of their wait-list control period.

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
690 Previous Clinical Trials
1,019,393 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,453,264 Total Patients Enrolled
Judith P Andersen, PhDPrincipal InvestigatorUniversity of Toronto

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability for participants in this research endeavor?

"Affirmative. Current data hosted on clinicaltrials.gov denotes that this medical research, which was initially posted on January 30th 2023, is actively seeking suitable candidates. Approximately 250 patients need to be sourced from 1 site."

Answered by AI

What is the current enrollment capacity of this research trial?

"Yes, up-to-date information on clinicaltrials.gov indicates that this trial is recruiting patients as of November 29th 2023. The study was initially posted in January 30th and currently seeks to enroll 250 participants at 1 particular site."

Answered by AI
~143 spots leftby Dec 2025